Pontifax participates in $110m funding round in ninth deal from debut fund

Precision BioSciences will use the capital raised to extend its gene-editing technology from human therapeutics to the agri-food industry.

To view this content you must sign in:

Not yet registered? Join today to access Agri Investor's industry insights and updates.